NCER states position on use of CRISPR/Cas-9
Nebraska Coalition for Ethical Research encourages the continued use of CRISPR/Cas-9 in animal research and in adult human cell cultures as a means toward it’s eventual safe and efficacious use for the correction of disease genes in adult human beings.
NCER agrees with the calls for a self-imposed moratorium and an international meeting on the use of CRISPR/Cas-9 for germline genetic engineering on human embryos or human germ cells.
However, regardless of the outcome of …
Jun
A guide to CRISPR, the human gene-editing tool that has scientists excited — and terrified
We are now one step closer to designer babies. Using a technique called CRISPR, geneticists in China recently modified the DNA of nonviable human embryos and published the results in the journal Protein & Cell.
Editing the genetic material of human embryos was a first — and the April 18 publication of the results set off a cascade of awe and controversy.
“While these embryos will not be growing up into genetically modified people,” …
NHS to give volunteers ‘synthetic blood’ made in laboratory within two years
as seen in THE INDEPENDENT
- SUNDAY 28 JUNE 2015
The first attempt at giving human volunteers “synthetic blood” made in a laboratory for the first time will take place within the next two years, the NHS has announced.
…
Gene, stem cell therapies may have far-reaching implications for coronary artery grafts
As seen in Science Daily – June 9, 2015
Source:Creighton University
Summary:Researchers are exploring the potential for gene and stem cell therapy in coronary artery bypass grafts to prevent re-occlusion in the grafted vein. Based on animal studies, the team is seeing a marked improvement in preventing re-occlusion, with no side effects
A Creighton University researcher has received a National Institutes of Health grant to study the effects of gene and stem cell therapy in …
Jun